John C. Dwyer is partner-in-charge of the Palo Alto office and a member of the firm’s board of directors. His
practice includes a variety of litigation, negotiation and counseling services in both civil and criminal matters.

He has developed substantial expertise in numerous areas, including securities law; officer and director
liability matters; mergers and acquisitions litigation; antitrust; white collar litigation and professional liability matters. John has successfully represented a wide range of public companies and their officers and directors in actions arising under federal and state securities laws.

He regularly represents such clients in civil class actions as well as in investigations and proceedings brought by the Securities & Exchange Commission and the US Department of Justice. Recently, he secured a major victory for Rigel Pharmaceuticals resulting in an important decision by the US Court of Appeals for the Ninth Circuit with significant implications for all publicly-traded life sciences companies. He also has extensive experience litigating cases arising from corporate acquisitions and other major corporate transactions. He has handled such cases in Delaware courts as well as other courts around the country.

John also has substantial antitrust expertise. He has represented major US and foreign corporations in
criminal antitrust matters involving the US Department of Justice and other competition authorities around the world. He also has substantial expertise representing such clients in civil antitrust litigation.

In addition to representing clients in federal and state courts, John regularly advises public and private
companies and their officers and directors on a broad range of issues regarding fiduciary duties, disclosure
matters, litigation strategy and compliance matters. He has also conducted numerous special investigations
into allegations of possible misconduct on behalf of corporate boards and board committees.

Representative corporate clients include Adobe, AMAG Pharmaceuticals, Brocade Communications
Systems, Dow Chemical, eBay, Ernst & Young, Gilead Sciences, Jazz Pharmaceuticals, Medivation,
NVIDIA, Power Integrations, Rigel Pharmaceuticals, Sony and Zynga.

Cooley LLP

Why Cooley